Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section listing study sites (California, Colorado, District of Columbia, Illinois, New York, Ohio, Pennsylvania, Tennessee, Texas, Ontario). Updated revision tag from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check58 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to core study content or metadata were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedRemoval of the government funding status notice from the page; core study information such as eligibility criteria, interventions, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check108 days agoChange DetectedAdded a government-operating-status notice and a new version tag v3.2.0; removed the previous version tag v3.1.0. Overall, a significant update to status messaging and versioning.SummaryDifference2%

- Check115 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.